Genomes and Genes
Angela G Fleischman
Affiliation: Oregon Health and Science University
- TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasmsAngela G Fleischman
Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA
Blood 118:6392-8. 2011....
- Hematopoietic stem cell transplantation for myelofibrosis: where are we now?Angela G Fleischman
Division of Hematology and Medical Oncology, Center for Hematologic Malignancies, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97239, USA
Curr Opin Hematol 20:130-6. 2013..A succinct yet comprehensive review of the biology of myeloproliferative neoplasms and therapeutic options with a focus on rational decision making for hematopoietic stem cell transplantation...
- Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CMLJulia E Maxson
Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA
N Engl J Med 368:1781-90. 2013....
- Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CMLAnupriya Agarwal
Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Blood 120:2658-68. 2012..Beneficial effects of combining tyrosine kinase inhibitors with plerixafor may be observed in a situation of minimal residual disease, but caution is warranted when disease control is incomplete...